by Nathaniel Harding | May 11, 2022 | Uncategorized
Cortado Ventures Reaches First Close of Fund II First $20M committed in under 6 weeks Oklahoma City, Oklahoma – May 11, 2022 – In less than two months, venture capital firm Cortado Ventures raised the first $20 million of its $80 million seed Fund II,...
by Nathaniel Harding | Feb 6, 2022 | Uncategorized
405 Business Magazine published an article this month highlighting Cortado’s funding of Sensulin, a biopharmaceutical company that is developing a glucose-responsive insulin for Type 1 and Type 2 diabetes. 405 Business Magazine focuses on sharing stories on local...
